Doctors have an arsenal of Covid-19 treatments, but setbacks and shortages are undercutting options

(By Andrew Joseph for STAT)

On paper, the list of outpatient treatments for Covid-19 seems reassuring.

Two oral antivirals have arrived, companies have churned out monoclonal antibody treatments, and all of them, to varying degrees, can help prevent patients from getting so sick they need to be hospitalized. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org